Treatment Patterns and Survival Outcomes Among Patients With Hepatocellular Carcinoma.

ABSTRACT:

Importance

The treatment landscape for hepatocellular carcinoma (HCC) is rapidly evolving, with the approval of multiple systemic therapies for patients with advanced disease since 2017. However, ideal treatment sequencing approaches remain unknown, and data on clinical practice patterns are limited.

Objective

To evaluate current treatment patterns, sequencing, and survival outcomes among patients receiving systemic therapy for HCC.

Design, setting, and participants

This retrospective cohort study used data from a nationwide electronic health record (EHR)-derived database of more than 280 oncology practices at more than 800 US cancer clinics to assess adult patients who were treated with systemic therapy for HCC from January 1, 2011, to December 31, 2023.

Exposure<

SUBMITTER: Lau-Min KS 

PROVIDER: S-EPMC12754679 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature